BioCina is a global end-to-end biologics CDMO and the only biologics CDMO in Australia approved by the US FDA. Following the merger with NovaCina, the company provides comprehensive biologics CDMO services spanning cell line development, process development, analytical development, GMP manufacturing of biologics drug substance and drug product, and mRNA manufacturing. Operates facilities in Adelaide, Australia with GMP manufacturing capacity up to 1,000L bioreactors.
biologics manufacturing, mRNA manufacturing, monoclonal antibodies, cell line development, process development, FDA-approved Australian CDMO
1 site worldwide
No reviews available yet.
No documents available.